Click on icon to see table/diagram/image
Breast discharge may occur during use of Azalia. On rare occasions, ectopic pregnancies may occur (see "Precautions"). In addition, (aggravation of) angioedema and/or aggravation of hereditary angioedema may occur (see "Precautions").
In women using (combined) oral contraceptives a number of (serious) undesirable effects have been reported. These include venous thromboembolic disorders, arterial thromboembolic disorders, hormone-dependent tumours (e.g. liver tumours, breast cancer) and chloasma, some of which are discussed in more detail in "Precautions".
Reporting of suspected adverse reactions: Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting.
View ADR Monitoring Form